Posted on 26/04/2017 / 1787

With Genematics we approach a new way in tackling growing costs in healthcare, resistant bacteria against modern drugs and scarcity in food around the world.

By giving researchers and medical doctors more insight in their biological data, new findings and possible solutions can be generated. We bring big data analysis, scientific knowledge sharing and an easy to use platform in an affordable service to all businesses and institutes around the globe. 

CATEGORY : BIOTECH
GROEI FASE : EARLY GROWTH
WHAT IS YOUR TARGET MARKET? : GLOBAL
B2B or B2C : B2B
OPEN FOR INVESTMENTS : YES
HOW MUCH INVESTMENT NEEDED ? : 100-200K
REVENUE MODEL : SUBSCRIPTION, PAY FOR SERVICE, LICENCE FEE
SALES CHANNELS : SAAS, SOFTWARE
ANNUAL TURNOVER : < 500K
LOCATION [CITY] : Malden
FOUNDED : 2016
TEAM SIZE : 5
AWARDS / ADDITIONS / FEATURES / NEED TO KNOWS / USP'S / UBR'S
BOOTCAMP ALUMNI
DELOITTE FAST 50 UK
DELOITTE FAST 500 EMEA
FAST GROWTH
PATENTED TECH EUROPE
PATENTED TECH US
PATENTED TECH WORLD
PROFITABLE
STARTUP FINALIST
TECH ALL STARS 2013
TECH ALL STARS 2014
TECH ALL STARS 2015
TECH ALL STARS 2016
TECH TOUR 50
THE EUROPAS NOMINEE
TOP INNOVATOR
UNICORN
UNIQUE TECHNOLOGY
Reviews
5
Total Score 2 REVIEWS
I LIKE THIS STARTUP!:
Leave a review
I LIKE THIS STARTUP!:

Leave a Reply

Related Listings